CN104080775A - 立体选择性合成1,4-保护的9-羟基-5-氧代-1,4-二氮杂-螺[5.5]十一烷的方法 - Google Patents

立体选择性合成1,4-保护的9-羟基-5-氧代-1,4-二氮杂-螺[5.5]十一烷的方法 Download PDF

Info

Publication number
CN104080775A
CN104080775A CN201380006918.0A CN201380006918A CN104080775A CN 104080775 A CN104080775 A CN 104080775A CN 201380006918 A CN201380006918 A CN 201380006918A CN 104080775 A CN104080775 A CN 104080775A
Authority
CN
China
Prior art keywords
formula
compound
optionally
reaction
tautomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380006918.0A
Other languages
English (en)
Chinese (zh)
Inventor
J.希瑙贝尔特
W.唐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of CN104080775A publication Critical patent/CN104080775A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CN201380006918.0A 2012-02-09 2013-02-06 立体选择性合成1,4-保护的9-羟基-5-氧代-1,4-二氮杂-螺[5.5]十一烷的方法 Pending CN104080775A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12154688 2012-02-09
EP12154688.1 2012-02-09
PCT/EP2013/052287 WO2013117568A1 (de) 2012-02-09 2013-02-06 Verfahren zur stereoselektiven synthese von 1,4-geschützten 9-hydroxy-5-oxo-1,4-diaza-spiro [5.5] undecane

Publications (1)

Publication Number Publication Date
CN104080775A true CN104080775A (zh) 2014-10-01

Family

ID=47678813

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380006918.0A Pending CN104080775A (zh) 2012-02-09 2013-02-06 立体选择性合成1,4-保护的9-羟基-5-氧代-1,4-二氮杂-螺[5.5]十一烷的方法

Country Status (14)

Country Link
US (1) US8629146B2 (https=)
EP (1) EP2812317B1 (https=)
JP (1) JP6105631B2 (https=)
KR (1) KR20140128318A (https=)
CN (1) CN104080775A (https=)
AU (1) AU2013218119A1 (https=)
BR (1) BR112014019196A8 (https=)
CA (1) CA2862520A1 (https=)
CL (1) CL2014001823A1 (https=)
EA (1) EA201400882A1 (https=)
IL (1) IL233370A (https=)
MX (1) MX2014009033A (https=)
PH (1) PH12014501760A1 (https=)
WO (1) WO2013117568A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2289881A1 (de) * 2009-08-06 2011-03-02 Boehringer Ingelheim International GmbH Verfahren zur stereoselektiven Synthese bicyclischer Heterocyclen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
CA2476008C (en) 2002-03-30 2011-12-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
US6924285B2 (en) 2002-03-30 2005-08-02 Boehringer Ingelheim Pharma Gmbh & Co. Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
BRPI0619603A2 (pt) 2005-12-12 2011-10-11 Boehringer Ingelheim Int heterociclos bicìclicos, sais fisiologicamante compatìveis, medicamentos que contêm esses compostos, bem como uso e processos para produção dos heterociclos bicìclicos
CA2711582A1 (en) 2008-02-07 2009-08-13 Boehringer Ingelheim International Gmbh Spirocyclic heterocycles, formulations containing said compounds, use thereof and processes for the preparation thereof
EP2289881A1 (de) 2009-08-06 2011-03-02 Boehringer Ingelheim International GmbH Verfahren zur stereoselektiven Synthese bicyclischer Heterocyclen
EA023573B1 (ru) 2011-02-01 2016-06-30 Бёрингер Ингельхайм Интернациональ Гмбх Дималеат 9-[4-(3-хлор-2-фторфениламино)-7-метоксихиназолин-6-илокси]-1,4-диазаспиро[5.5]ундекан-5-она, его применение в качестве лекарственного средства и его получение

Also Published As

Publication number Publication date
CA2862520A1 (en) 2013-08-15
EP2812317B1 (de) 2016-02-03
JP2015506966A (ja) 2015-03-05
PH12014501760B1 (en) 2014-11-10
CL2014001823A1 (es) 2015-03-06
MX2014009033A (es) 2014-10-17
EA201400882A1 (ru) 2015-01-30
US8629146B2 (en) 2014-01-14
PH12014501760A1 (en) 2014-11-10
EP2812317A1 (de) 2014-12-17
IL233370A (en) 2015-04-30
KR20140128318A (ko) 2014-11-05
AU2013218119A1 (en) 2014-07-17
US20130211081A1 (en) 2013-08-15
BR112014019196A8 (pt) 2017-07-11
JP6105631B2 (ja) 2017-03-29
BR112014019196A2 (https=) 2017-06-20
IL233370A0 (en) 2014-08-31
WO2013117568A1 (de) 2013-08-15

Similar Documents

Publication Publication Date Title
CN110330500B (zh) 一种6β-羟基-7,8-二氢-吗啡衍生物的立体选择性合成方法
DK2462126T3 (en) Process for stereoselective synthesis of bicyclic heterocyclic compounds.
CN110015978B (zh) O-[2-[[叔丁氧羰基]氨基]乙基]-n-[芴甲氧羰基]-l-酪氨酸的合成方法
CN110092786B (zh) 吴茱萸碱的制造方法
CN103113290B (zh) 一种巴洛沙星中间体的制备方法
CN104080775A (zh) 立体选择性合成1,4-保护的9-羟基-5-氧代-1,4-二氮杂-螺[5.5]十一烷的方法
CN107056681B (zh) 一种托法替布中间体的制备方法
RU2405787C2 (ru) Способ получения 4бета-амино-4'-деметил-4-дезоксиподофиллотоксина
WO2020182227A1 (zh) 一种高纯度利拉鲁肽侧链的制备方法
CN106278928B (zh) 一种磷酸奥司他韦异构体杂质的合成方法
CN115477635B (zh) 一种拉司米地坦的制备方法
CN115521317B (zh) 一种制备纳呋拉啡中间体的方法
CN104334561A (zh) 化合物jk12a及其制备
CA2731895C (en) Process for the stereoselective preparation of bicyclic heterocycles
CN100475811C (zh) 地舍平的半合成方法
CN118339161B (zh) 一种异噻唑并[5,4-d]嘧啶类IRAK4抑制剂的制备方法
CN112745370B (zh) 一种泰拉霉素的制备方法
CN114835730B (zh) 一种制备多环氨基甲酰基吡啶酮化合物的方法
CN103819466B (zh) 一种药物活性化合物Cephalandole A的合成方法
CN114105961A (zh) 一种ido1抑制剂(ly-3381916)制备方法
KR100696187B1 (ko) 2-(2-아미노에틸)-1-메틸피롤리딘의 제조방법
CN115703733A (zh) 一种普芦卡必利中间体的制备方法
CN104311473A (zh) 一种哌啶类化合物及其制备方法
CN113979977A (zh) 一种六元氧杂环化合物及其合成方法
CN102453025B (zh) 拉帕替尼中间体晶型及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20141001